Botulinum neurotoxin is one of the most potent toxins among Category-A biothreat agents, yet a post-exposure therapeutic is not available. The high content imaging approach is a powerful methodology for identifying novel inhibitors as it enables multiparameter screening using biologically relevant motor neurons, the primary target of this toxin.
Kota, K. P., Soloveva, V., Wanner, L. M., Gomba, G., Kiris, E., Panchal, R. G., Kane, C. D., Bavari, S. A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors. J. Vis. Exp. (93), e51915, doi:10.3791/51915 (2014).